Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Non-cash Items (2016)

Viridian Therapeutics, Inc.\DE has reported Non-cash Items over the past 3 years, most recently at $37465.0 for Q4 2016.

  • Quarterly results put Non-cash Items at $37465.0 for Q4 2016, down 51.97% from a year ago — trailing twelve months through Dec 2016 was $37465.0 (down 51.97% YoY), and the annual figure for FY2016 was $37465.0, down 51.97%.
  • Non-cash Items for Q4 2016 was $37465.0 at Viridian Therapeutics, Inc.\DE, down from $262194.0 in the prior quarter.
  • Over the last five years, Non-cash Items for VRDN hit a ceiling of $407000.0 in Q1 2015 and a floor of $2000.0 in Q2 2015.
  • Median Non-cash Items over the past 3 years was $132378.0 (2016), compared with a mean of $167293.2.
  • Biggest five-year swings in Non-cash Items: tumbled 80.1% in 2015 and later skyrocketed 7339.9% in 2016.
  • Viridian Therapeutics, Inc.\DE's Non-cash Items stood at $392000.0 in 2014, then tumbled by 80.1% to $78009.0 in 2015, then tumbled by 51.97% to $37465.0 in 2016.
  • The last three reported values for Non-cash Items were $37465.0 (Q4 2016), $262194.0 (Q3 2016), and $148798.0 (Q2 2016) per Business Quant data.